Abstract
Background While general population studies have shown associations between greater physical activity and lower inflammatory markers, effects of physical activity on inflammatory pathways in rheumatoid arthritis (RA) remain unknown. We aimed to determine whether physical activity independently associates with differential expression of inflammatory genes in RA.
Methods Data derived from an observational RA cohort. Physical activity was measured with the GT9X ActiGraph Link device. RNA extraction from peripheral blood, sequencing library preparation and transcriptomic analyses were performed using established methods. Genes differentially expressed in the most versus least physically active groups (top versus bottom activity tertiles) were identified using DESeq2 after adjusting for sex, age, race/ethnicity, and disease activity. Ingenuity Pathway Analysis (IPA) was employed to identify canonical biological pathways and upstream regulating cytokines associated with physical activity.
Results 35 participants were enrolled (mean age 56±12 years; 91% female; race/ethnicity 31% white, 9% African American, 9% Asian, 40% Hispanic). 767 genes were differentially expressed (padj<0.1) between high versus low activity groups. The high activity group exhibited downregulation of innate and adaptive immune signaling pathways, including CD40, STAT3, TREM-1, IL-17a, IL-8, toll-like receptor and interferon signaling. Upstream cytokine analysis demonstrated inhibition of TNF-alpha and interferon among individuals in the most active group.
Conclusion In a racially diverse RA cohort, patients who were more physically active had lower expression of immune signaling pathways implicated in RA pathogenesis, even after adjusting for disease activity, suggesting a potential protective effect of physical activity in RA.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This work is supported by NIH/NIAMS R01 AR069616 and NIH/NHLBI K23HL138461-01A1. Additional support from the Rheumatology Research Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The UCSF Institutional Review Board approved all procedures (UCSF IRB protocol #17-21790) and all participants provided written informed consent.
All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Competing interests: The authors declare no competing interests.
Data Availability
Genecounts are available under Gene Expression Omnibus accession number GSE179302. All code is available at Github https://github.com/drychkov/PA_in_RA.
